GPHRA

gene
On this page

Also known as GPHRUNQ192

Summary

GPHRA (golgi pH regulator A, HGNC:31984) is a protein-coding gene on chromosome 1q21.1, encoding Golgi pH regulator A (B7ZAQ6). Voltage-gated channel that enables the transfer of monoatomic anions such as iodide, chloride, bromide and fluoride which may function in counter-ion conductance and participates in Golgi acidification.

Enables voltage-gated monoatomic anion channel activity. Involved in intracellular pH reduction. Located in Golgi cisterna membrane and Golgi-associated vesicle membrane.

Source: NCBI Gene 653519 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 57 total — 1 likely-pathogenic
  • MANE Select transcript: NM_001097612

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31984
Approved symbolGPHRA
Namegolgi pH regulator A
Location1q21.1
Locus typegene with protein product
StatusApproved
AliasesGPHR, UNQ192
Ensembl geneENSG00000117262
Ensembl biotypeprotein_coding
OMIM612821
Entrez653519

Gene structure

Transcript identifiers

Ensembl transcripts: 23 — 13 protein_coding, 4 nonsense_mediated_decay, 4 retained_intron, 2 protein_coding_CDS_not_defined

ENST00000313835, ENST00000460277, ENST00000462900, ENST00000465185, ENST00000466593, ENST00000478703, ENST00000492401, ENST00000493684, ENST00000524525, ENST00000527989, ENST00000528944, ENST00000532574, ENST00000534502, ENST00000907153, ENST00000907154, ENST00000907155, ENST00000907156, ENST00000907157, ENST00000907158, ENST00000907159, ENST00000907160, ENST00000918431, ENST00000960869

RefSeq mRNA: 2 — MANE Select: NM_001097612 NM_001097612, NM_001097613

CCDS: CCDS72857, CCDS72858

Canonical transcript exons

ENST00000313835 — 14 exons

ExonStartEnd
ENSE00001597907145623613145623714
ENSE00001863261145669834145670650
ENSE00003473687145665562145665651
ENSE00003476736145646184145646272
ENSE00003514696145623054145623160
ENSE00003518078145663329145663424
ENSE00003548922145647175145647267
ENSE00003553143145669625145669690
ENSE00003555340145643869145643978
ENSE00003559230145616234145616293
ENSE00003595763145631664145631744
ENSE00003625983145630687145630807
ENSE00003668603145618320145618423
ENSE00003846947145607988145608175

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 91.42.

FANTOM5 (CAGE): breadth broad, TPM avg 0.9157 / max 13.2807, expressed in 607 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
2016700.9157607

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
corpus callosumUBERON:000233691.42gold quality
duodenumUBERON:000211491.32gold quality
body of pancreasUBERON:000115089.98gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047389.90gold quality
pancreasUBERON:000126488.88gold quality
endometriumUBERON:000129588.80gold quality
cerebellar cortexUBERON:000212988.57gold quality
cerebellar hemisphereUBERON:000224588.54gold quality
cerebellumUBERON:000203788.53gold quality
adrenal tissueUBERON:001830388.34gold quality
rectumUBERON:000105288.32gold quality
right hemisphere of cerebellumUBERON:001489088.28gold quality
calcaneal tendonUBERON:000370188.19gold quality
right lobe of liverUBERON:000111488.00gold quality
islet of LangerhansUBERON:000000687.99gold quality
body of stomachUBERON:000116187.67gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099187.57gold quality
left adrenal gland cortexUBERON:003582587.55gold quality
smooth muscle tissueUBERON:000113587.46gold quality
left adrenal glandUBERON:000123487.43gold quality
adult mammalian kidneyUBERON:000008287.32gold quality
right adrenal glandUBERON:000123387.26gold quality
right adrenal gland cortexUBERON:003582787.24gold quality
adrenal glandUBERON:000236987.16gold quality
stomachUBERON:000094587.05gold quality
pituitary glandUBERON:000000787.04gold quality
cortex of kidneyUBERON:000122587.02gold quality
kidneyUBERON:000211387.00gold quality
adenohypophysisUBERON:000219686.95gold quality
small intestineUBERON:000210886.87gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.92
E-CURD-112no3.60

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

26 targeting GPHRA, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-806899.9873.852376
HSA-MIR-4799-5P99.8270.602663
HSA-MIR-132-3P99.7370.561424
HSA-MIR-212-3P99.7370.651424
HSA-MIR-6892-3P99.6866.401178
HSA-MIR-3679-3P99.6469.881599
HSA-MIR-24-3P99.5969.971934
HSA-MIR-199A-5P99.5169.711107
HSA-MIR-199B-5P99.5169.741098
HSA-MIR-20B-3P99.2967.05784
HSA-MIR-3064-5P99.2666.131497
HSA-MIR-3085-3P99.2666.161490
HSA-MIR-6504-5P99.2665.951487
HSA-MIR-593-3P99.2267.281327
HSA-MIR-6744-3P99.2264.41972
HSA-MIR-807799.1766.67862
HSA-MIR-4757-5P99.1264.51981
HSA-MIR-29A-5P99.0868.591813
HSA-MIR-62298.9966.481050
HSA-MIR-6728-3P98.6367.631534
HSA-MIR-218-1-3P98.6367.97832
HSA-MIR-93-3P98.1566.651309
HSA-MIR-446997.9365.811319
HSA-MIR-937-5P97.4368.39667
HSA-MIR-3622A-3P97.0666.431000
HSA-MIR-3622B-3P96.8266.36988

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_rerioGPR89AENSDARG00000077983
mus_musculusGpr89ENSMUSG00000028096
rattus_norvegicusGpr89bENSRNOG00000000095
drosophila_melanogasterGPHRFBGN0033995
caenorhabditis_elegansWBGENE00007528
caenorhabditis_elegansWBGENE00013551

Paralogs (1): GPR89B (ENSG00000188092)

Protein

Protein identifiers

Golgi pH regulator AB7ZAQ6 (reviewed: B7ZAQ6)

Alternative names: Protein GPR89A, Putative MAPK-activating protein PM01, Putative NF-kappa-B-activating protein 90

All UniProt accessions (5): B7ZAQ6, E9PKY3, E9PRZ5, X5D7G6, X5DNN3

UniProt curated annotations — full annotation on UniProt →

Function. Voltage-gated channel that enables the transfer of monoatomic anions such as iodide, chloride, bromide and fluoride which may function in counter-ion conductance and participates in Golgi acidification. Plays a role in lymphocyte development, probably by acting as a RABL3 effector in hematopoietic cells.

Subunit / interactions. Homotrimer. Interacts with RABL3; the interaction stabilizes GPR89A.

Subcellular location. Golgi apparatus membrane.

Tissue specificity. Ubiquitous.

Miscellaneous. Does not seem to be able to bind GTP.

Similarity. Belongs to the Golgi pH regulator (TC 1.A.38) family.

Isoforms (4)

UniProt IDNamesCanonical?
B7ZAQ6-11yes
B7ZAQ6-22
B7ZAQ6-33
B7ZAQ6-44, A

RefSeq proteins (2): NP_001091081, NP_001091082 (=MANE)

Domains & families (InterPro)

IDNameType
IPR015672GPHR/GTGFamily
IPR022535Golgi_pH-regulator_cons_domDomain
IPR025969ABA_GPCR_domDomain

Pfam: PF12430, PF12537

Catalyzed reactions (Rhea), 4 shown:

  • chloride(in) = chloride(out) (RHEA:29823)
  • iodide(out) = iodide(in) (RHEA:66324)
  • bromide(in) = bromide(out) (RHEA:75383)
  • fluoride(in) = fluoride(out) (RHEA:76159)

UniProt features (19 total): transmembrane region 9, splice variant 4, sequence conflict 3, glycosylation site 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-B7ZAQ6-F182.620.35

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 180, 243

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 80 (showing top): GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GOCC_GOLGI_ASSOCIATED_VESICLE, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, SANSOM_APC_TARGETS_DN, GOBP_REGULATION_OF_PH, GOBP_MONOATOMIC_ION_HOMEOSTASIS, MORI_PLASMA_CELL_UP, GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_GOLGI_STACK, chr1q21, GOCC_GOLGI_ASSOCIATED_VESICLE_MEMBRANE, GOCC_GOLGI_CISTERNA, GOBP_HOMEOSTATIC_PROCESS

GO Biological Process (7): protein transport (GO:0015031), T cell differentiation (GO:0030217), positive regulation of canonical NF-kappaB signal transduction (GO:0043123), intracellular pH reduction (GO:0051452), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220), monoatomic anion transmembrane transport (GO:0098656)

GO Molecular Function (1): voltage-gated monoatomic anion channel activity (GO:0008308)

GO Cellular Component (6): Golgi membrane (GO:0000139), Golgi-associated vesicle membrane (GO:0030660), Golgi cisterna membrane (GO:0032580), monoatomic ion channel complex (GO:0034702), Golgi apparatus (GO:0005794), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport2
bounding membrane of organelle2
intracellular protein localization1
establishment of protein localization1
lymphocyte differentiation1
T cell activation1
canonical NF-kappaB signal transduction1
regulation of canonical NF-kappaB signal transduction1
positive regulation of intracellular signal transduction1
regulation of intracellular pH1
monoatomic ion transport1
transmembrane transport1
monoatomic anion transport1
monoatomic ion transmembrane transport1
voltage-gated monoatomic ion channel activity1
monoatomic anion channel activity1
Golgi apparatus1
Golgi-associated vesicle1
cytoplasmic vesicle membrane1
organelle membrane1
Golgi cisterna1
transmembrane transporter complex1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

908 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GPHRACT47A11Q5JQC4952
GPHRACT47B1P0C2W7766
GPHRAACP6Q9NPH0636
GPHRAFSHRP23945602
GPHRATSHRP16473599
GPHRAPRKAB2O43741595
GPHRAFMO5P49326576
GPHRAPOLR3GLQ9BT43539
GPHRACHD1LQ86WJ1530
GPHRABOLA2Q9H3K6528
GPHRAGPHNQ9NQX3515
GPHRALHCGRP22888512
GPHRAGPR152Q8TDT2508
GPHRANBPF11Q86T75507
GPHRAGTPBP8Q8N3Z3488

IntAct

111 interactions, top by confidence:

ABTypeScore
NIPAL1ESYT2psi-mi:“MI:0914”(association)0.640
SLC7A1TMEM223psi-mi:“MI:0914”(association)0.530
IPPKTMEM223psi-mi:“MI:0914”(association)0.530
SLC39A5TMEM223psi-mi:“MI:0914”(association)0.530
CXCR4TMEM120Bpsi-mi:“MI:0914”(association)0.530
GPR21TMEM120Bpsi-mi:“MI:0914”(association)0.530
YIPF3TMEM120Bpsi-mi:“MI:0914”(association)0.530
SLC39A4TMEM120Bpsi-mi:“MI:0914”(association)0.530
C3AR1TMEM120Bpsi-mi:“MI:0914”(association)0.530
LPAR1TMEM120Bpsi-mi:“MI:0914”(association)0.530
HTR2CKLRG2psi-mi:“MI:0914”(association)0.530
TSPAN17UPK3BL1psi-mi:“MI:0914”(association)0.530
SLC1A5GPR89Apsi-mi:“MI:0914”(association)0.530
SLC22A9GPR89Apsi-mi:“MI:0914”(association)0.530
UNC93B1GPR89Apsi-mi:“MI:0914”(association)0.530
P2RY6ESYT2psi-mi:“MI:0914”(association)0.350
SLC15A3psi-mi:“MI:0914”(association)0.350
UNC93B1psi-mi:“MI:0914”(association)0.350
P2RY6psi-mi:“MI:0914”(association)0.350
repGPR89Apsi-mi:“MI:0914”(association)0.350
TMEM223psi-mi:“MI:0914”(association)0.350
MDENND11psi-mi:“MI:0914”(association)0.350
ATP2B2ESYT2psi-mi:“MI:0914”(association)0.350
TTYH1TMEM223psi-mi:“MI:0914”(association)0.350
TSPAN15TMEM223psi-mi:“MI:0914”(association)0.350
BSCL2TMEM223psi-mi:“MI:0914”(association)0.350
ADGRE5TMEM223psi-mi:“MI:0914”(association)0.350
CRELD1TMEM223psi-mi:“MI:0914”(association)0.350

BioGRID (246): GPR89A (Affinity Capture-MS), GPR89A (Affinity Capture-MS), GPR89B (Affinity Capture-MS), GPR89B (Affinity Capture-MS), GPR89A (Affinity Capture-MS), GPR89A (Affinity Capture-MS), GPR89B (Affinity Capture-MS), GPR89A (Affinity Capture-MS), GPR89B (Affinity Capture-MS), GPR89A (Affinity Capture-MS), GPR89B (Affinity Capture-MS), GPR89B (Affinity Capture-MS), GPR89A (Affinity Capture-MS), GPR89B (Affinity Capture-MS), GPR89B (Affinity Capture-MS)

ESM2 similar proteins: B2ZXD5, B5X1G3, B7ZAQ6, B9RK42, O95214, P0CG08, Q0VGV9, Q32PD8, Q3B8G4, Q3SYY9, Q3ZBX1, Q4R5E3, Q5BIM9, Q5E9M1, Q5F3F5, Q5F433, Q5F448, Q5PQQ4, Q5PR61, Q5RDE9, Q5U4X7, Q5ZI05, Q658I5, Q68DH5, Q6AZ61, Q6CLZ9, Q6DDW6, Q6DFS0, Q6IQC7, Q6P4P2, Q6PDU4, Q7SYR6, Q7ZUA6, Q7ZX75, Q7ZYA0, Q8BH79, Q8BS95, Q8C561, Q8GWT5, Q8K0B2

Diamond homologs: A2XX57, B2ZXD5, B5X1G3, B7ZAQ6, P0CG08, Q0WQG8, Q54QM5, Q5BIM9, Q5F448, Q6DDW6, Q7X7S8, Q8BS95, Q9XIP7

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 113 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Amino acid transport across the plasma membrane730.1×2e-07
SLC-mediated transport of neurotransmitters529.1×2e-05
R-HSA-425366820.7×2e-07
R-HSA-425393814.8×2e-06
SLC-mediated transmembrane transport1411.8×1e-09
G alpha (q) signalling events108.2×1e-05
Cardiac conduction57.8×5e-03
Transport of small molecules186.5×1e-08

GO biological processes:

GO termPartnersFoldFDR
complement receptor mediated signaling pathway556.7×2e-06
amino acid transport1031.5×4e-10
adenylate cyclase-modulating G protein-coupled receptor signaling pathway517.0×5e-04
sodium ion transmembrane transport816.4×3e-06
transport across blood-brain barrier916.3×7e-07
phospholipase C-activating G protein-coupled receptor signaling pathway1216.0×4e-09
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway613.3×4e-04
positive regulation of cytosolic calcium ion concentration910.6×2e-05

Disease & clinical

Clinical variants and AI predictions

ClinVar

57 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance42
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
1331349NC_000001.10:g.145382933_145831892delLikely pathogenic

SpliceAI

2637 predictions. Top by Δscore:

VariantEffectΔscore
1:145616230:T:Aacceptor_loss1.0000
1:145616231:C:CCacceptor_gain1.0000
1:145616231:C:CGacceptor_loss1.0000
1:145616232:TCTG:Tacceptor_loss1.0000
1:145616233:ATCT:Aacceptor_loss1.0000
1:145616235:GTAT:Gacceptor_gain1.0000
1:145616292:CC:Cdonor_loss1.0000
1:145616293:A:AGdonor_loss1.0000
1:145616294:CAC:Cdonor_loss1.0000
1:145616295:TCAC:Tdonor_loss1.0000
1:145616296:CTCAC:Cdonor_loss1.0000
1:145616297:TCTCA:Tdonor_loss1.0000
1:145643969:T:TAdonor_gain1.0000
1:145643974:T:Adonor_gain1.0000
1:145663325:T:Aacceptor_loss1.0000
1:145663326:C:CCacceptor_gain1.0000
1:145663329:AGCC:Aacceptor_loss1.0000
1:145663330:TAGCC:Tacceptor_loss1.0000
1:145663423:C:CCdonor_gain1.0000
1:145663423:CAT:Cdonor_gain1.0000
1:145663424:A:ACdonor_gain1.0000
1:145663424:AC:Adonor_loss1.0000
1:145663425:TACAT:Tdonor_loss1.0000
1:145663426:TTA:Tdonor_loss1.0000
1:145663427:CTTA:Cdonor_loss1.0000
1:145663428:ACTT:Adonor_loss1.0000
1:145665551:A:Tacceptor_gain1.0000
1:145665552:C:CTacceptor_gain1.0000
1:145665552:C:Tacceptor_gain1.0000
1:145665555:C:CTacceptor_gain1.0000

AlphaMissense

3026 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS10910846 (1:145659481 G>A,C,T), RS111338698 (1:145659066 C>A,T), RS111383109 (1:145619259 A>C), RS111488177 (1:145641195 A>C), RS111533600 (1:145630557 A>T), RS111534447 (1:145634351 G>A), RS111649805 (1:145640511 A>G), RS111653456 (1:145652195 T>G), RS111698165 (1:145647104 G>A), RS111776936 (1:145659392 G>A), RS111781764 (1:145616956 G>C), RS111884698 (1:145620881 T>G), RS112052396 (1:145607628 G>C), RS112053125 (1:145666774 G>A,T), RS112067935 (1:145653884 T>A)

Disease associations

OMIM: gene MIM:612821 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases abundance, increases expression2
aristolochic acid Idecreases expression1
bisphenol Adecreases expression1
CGP 52608affects binding, increases reaction1
deguelinincreases expression1
abrineincreases expression1
pyrachlostrobinincreases expression1
jinfukangincreases expression1
Arsenicincreases abundance, increases expression1
Vehicle Emissionsincreases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Cannabidiolaffects cotreatment, decreases expression1
Cuprizoneaffects cotreatment, decreases expression1
Methyl Methanesulfonateincreases expression1
Rotenoneincreases expression1
Valproic Aciddecreases methylation1
Aflatoxin B1decreases methylation1
Cadmium Chloridedecreases expression1
Acrylamideincreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.